Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction - PubMed (original) (raw)
Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction
Masaki Ikeuchi et al. Circulation. 2005.
Abstract
Background: Mitochondrial DNA (mtDNA) copy number is decreased not only in mtDNA-mutation diseases but also in a wide variety of acquired degenerative and ischemic diseases. Mitochondrial transcription factor A (TFAM) is essential for mtDNA transcription and replication. Myocardial mtDNA copy number and TFAM expression both decreased in cardiac failure. However, the functional significance of TFAM has not been established in this disease state.
Methods and results: We have now addressed this question by creating transgenic (Tg) mice that overexpress human TFAM gene and examined whether TFAM could protect the heart from mtDNA deficiencies and attenuate left ventricular (LV) remodeling and failure after myocardial infarction (MI) created by ligating the left coronary artery. TFAM overexpression could ameliorate the decrease in mtDNA copy number and mitochondrial complex enzyme activities in post-MI hearts. Survival rate during 4 weeks of MI was significantly higher in Tg-MI than in wild-type (WT) littermates (WT-MI), although infarct size was comparable. LV cavity dilatation and dysfunction were significantly attenuated in Tg-MI. LV end-diastolic pressure was increased in WT-MI, and it was also reduced in Tg-MI. Improvement of LV function in Tg-MI was accompanied by a decrease in myocyte hypertrophy, apoptosis, and interstitial fibrosis as well as oxidative stress in the noninfarcted LV.
Conclusions: Overexpression of TFAM inhibited LV remodeling after MI. TFAM may provide a novel therapeutic strategy of cardiac failure.
Similar articles
- Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
Matsushima S, Ide T, Yamato M, Matsusaka H, Hattori F, Ikeuchi M, Kubota T, Sunagawa K, Hasegawa Y, Kurihara T, Oikawa S, Kinugawa S, Tsutsui H. Matsushima S, et al. Circulation. 2006 Apr 11;113(14):1779-86. doi: 10.1161/CIRCULATIONAHA.105.582239. Epub 2006 Apr 3. Circulation. 2006. PMID: 16585391 - Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, Wen J, Kubota T, Utsumi H, Takeshita A. Shiomi T, et al. Circulation. 2004 Feb 3;109(4):544-9. doi: 10.1161/01.CIR.0000109701.77059.E9. Epub 2004 Jan 26. Circulation. 2004. PMID: 14744974 - Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N, Wen J, Egashira K, Takeshita A. Hayashidani S, et al. Circulation. 2003 Oct 28;108(17):2134-40. doi: 10.1161/01.CIR.0000092890.29552.22. Epub 2003 Sep 29. Circulation. 2003. PMID: 14517168 - Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
Tsutsui H, Kinugawa S, Matsushima S. Tsutsui H, et al. Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Cardiovasc Res. 2009. PMID: 18854381 Review. - Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions.
Kang D, Kim SH, Hamasaki N. Kang D, et al. Mitochondrion. 2007 Feb-Apr;7(1-2):39-44. doi: 10.1016/j.mito.2006.11.017. Epub 2006 Dec 8. Mitochondrion. 2007. PMID: 17280879 Review.
Cited by
- Overexpression of TFAM or twinkle increases mtDNA copy number and facilitates cardioprotection associated with limited mitochondrial oxidative stress.
Ikeda M, Ide T, Fujino T, Arai S, Saku K, Kakino T, Tyynismaa H, Yamasaki T, Yamada K, Kang D, Suomalainen A, Sunagawa K. Ikeda M, et al. PLoS One. 2015 Mar 30;10(3):e0119687. doi: 10.1371/journal.pone.0119687. eCollection 2015. PLoS One. 2015. PMID: 25822152 Free PMC article. - Oxidative stress during mitochondrial biogenesis compromises mtDNA integrity in growing hearts and induces a global DNA repair response.
Pohjoismäki JL, Boettger T, Liu Z, Goffart S, Szibor M, Braun T. Pohjoismäki JL, et al. Nucleic Acids Res. 2012 Aug;40(14):6595-607. doi: 10.1093/nar/gks301. Epub 2012 Apr 15. Nucleic Acids Res. 2012. PMID: 22508755 Free PMC article. - Neuroprotective Effect of Nanodiamond in Alzheimer's Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 Signaling.
Alawdi SH, El-Denshary ES, Safar MM, Eidi H, David MO, Abdel-Wahhab MA. Alawdi SH, et al. Mol Neurobiol. 2017 Apr;54(3):1906-1918. doi: 10.1007/s12035-016-9762-0. Epub 2016 Feb 20. Mol Neurobiol. 2017. PMID: 26897372 - Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer's disease.
Oka S, Leon J, Sakumi K, Ide T, Kang D, LaFerla FM, Nakabeppu Y. Oka S, et al. Sci Rep. 2016 Nov 29;6:37889. doi: 10.1038/srep37889. Sci Rep. 2016. PMID: 27897204 Free PMC article. - LRP130 protein remodels mitochondria and stimulates fatty acid oxidation.
Liu L, Sanosaka M, Lei S, Bestwick ML, Frey JH Jr, Surovtseva YV, Shadel GS, Cooper MP. Liu L, et al. J Biol Chem. 2011 Dec 2;286(48):41253-41264. doi: 10.1074/jbc.M111.276121. Epub 2011 Oct 4. J Biol Chem. 2011. PMID: 21971050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous